InnovHeart is an Italian innovative PMI, with branches in USA, developing an innovative Transcatheter Mitral Valve Replacement (TMVR) system to treat patients suffering from mitral valve disease.
Founded in 2015 by Giovanni Righini, Innovheart has the mission to provide cardiologists and patients with a novel therapeutic system based on a safe, effective, and easy-to-use technology.
Saturn is a low-profile mitral heart valve for trans-apical or trans-septal delivery, currently in clinical phase.
The Company is targeting a huge and dynamic market with a strong medical unmet need.
Indaco Ventures I invested in InnovHeart in August 2020 (Series B).